Leukaemia

Post Views: 172
Cancer Leukaemia Oceania RESEARCHER PROFILE

Mechanisms of resistance to menin inhibitor therapy and Acute Myeloid Leukaemia

By Bench Side Story — 4 weeks ago

Dr Rithin Nedumannil (MBBS, MPH, FRACP, FRCPA) is a PhD candidate at the University of Melbourne, undertaking his doctoral studies in collaboration with the Cambridge Stem Cell Institute (Cambridge, UK) and the Peter MacCallum Cancer Centre (Melbourne, Australia). He is a clinical haematologist and haematopathologist with current appointments at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, Austin Health and Northern Health.

Post Views: 182
Leukaemia Oceania RESEARCH IMPACT

Impact of Leukaemia Foundation’s Research Funding into Blood Cancer

By Bench Side Story — 2 months ago

Bill Stavreski is the Head of Research at the Leukaemia Foundation who talks about the research impact in recent years. The Foundation itself marks its 25th anniversary in 2025, having funded a wide range of health and medical research since 2000. With a focus on basic science, health services research, treatment, and care, the organisation has invested nearly $90 million (adjusted in current dollars terms) in approximately 370 research grants over the years.

Post Views: 427
CASE STUDY Leukaemia Oceania

CASE STUDY Link between levels of extracellular vesicles in the blood and tissue damage caused by diseases

By Bench Side Story — 4 months ago

A landmark study led by WEHI and La Trobe University has found a potential new diagnostic marker that could be used to better detect the level of tissue damage in our bodies.

This study revealed, for the first time, a link between levels of EVs in the blood and tissue damage caused by diseases such as leukaemia.

Researchers hope to leverage the critical new insight to develop a blood test to monitor cancer patients with tissue damage, which could, in future, enhance treatment strategies for blood cancers and other diseases.

Post Views: 404
Genomics Leukaemia Oceania RESEARCHER PROFILE

Genomics and rationally targeted therapies in Acute Lymphoblastic Leukaemia

By Bench Side Story — 5 months ago

Prof Deborah White’s research focus is genomics and rationally targeted therapies in Acute Lymphoblastic Leukaemia (ALL) and Chronic Myeloid Leukaemia (CML) and she holds peer reviewed grants from: The William Lawrence and Blanche Hughes Foundation and the Leukemia Lymphoma Society (USA), the NHMRC, the Leukaemia Foundation Australia (LFA), Channel 7, Cancer Australia, Tour de Cure and the Cancer Council SA (CCSA). Professor White has presented more than 170 papers at scientific meetings, and authored more than 100 scientific publications as well as being an inventor on several international patents.

Post Views: 406
Leukaemia Oceania RESEARCHER PROFILE

Therapies for chronic myeloid leukaemia

By Bench Side Story — 7 months ago

Professor Tim Hughes is an international expert in the biology and treatment of leukaemia. He led the establishment of the molecular response criteria that are used world-wide to measure response in chronic myeloid leukaemia (CML) and has led many of the key Global and National trials. His group has successfully developed predictive bioassays and molecular targets that influence the way CML patients are managed world-wide. He has published over 350 papers that have been cited over 65,000 times. 

Scroll to top